Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

NCT04960618

Conditions
Advanced Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

NCT04566887

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • BC Cancer Agency Vancouver, British Columbia, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Sunnybrook Research Institute Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma

NCT03321643

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

NCT02537548

Conditions
Germinoma, Hemic and Lymphatic Diseases, Lymphadenopathy, +7 more
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Stanford University Hospitals & Clinics Stanford, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

NCT04282811

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Aou Arcispedale Sant'Anna - Cona (Fe) - Uoc Ematologia E Fisiopatologia Della Coagulazione Cona, Ferrara, Italy
  • Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia Alessandria, Italy
  • Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy
  • Ao Brotzu, Presidio Ospedaliero A. Businco - Cagliari - Sc Ematologia E Ctmo Cagliari, Italy
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL

NCT05658562

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Nagoya Medical Center Nagoya, Aichi-ken, Japan
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Kyushu Cancer Center Fukuoka, Japan
View all 23 locations
View Trial Details

Related conditions